Evidence map›Paper›PMID 26272535›Full record

ReviewNeuroscience2015

The placebo effect: From concepts to genes.

B Colagiuri, L A Schenk, M D Kessler, S G Dorsey, L Colloca

Registry-linked trialAbstract readReview
In one paragraph

Review in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03446456 (The Influence of Vasopressin on Observational Learning of Placebo Analgesia), which is not on this map. Cited by 101 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 5 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03446456 phase1 / phase2recruitingnot on this mapstarted 2018, after this paper: background citation

The Influence of Vasopressin on Observational Learning of Placebo Analgesia

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2018 to 2026Enrolled56ConditionsAcute PainArmsArginine vasopressin, Saline, Observational learning, fMRI data aquisition
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 5 syntheses or guidelines pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Subjective cognition and mood in persistent chemotherapy-related cognitive impairment.Journal of cancer survivorship : research and practice · 2022
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.Journal of cancer survivorship : research and practice · 2019
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

B ColagiuriUniversity of Sydney, School of Psychology, Australia.
L A SchenkUniversity Medical Center Hamburg-Eppendorf, Department of Systems Neuroscience, Hamburg, Germany.
M D KesslerUniversity of Maryland School of Medicine, Institute For Genome Sciences, Baltimore, USA.
S G DorseyUniversity of Maryland School of Nursing, Department of Pain and Translational Symptom Science, Baltimore, USA; University of Maryland School of Medicine, Department of Anesthesiology, Baltimore, USA; UM Center to Advance Chronic Pain Research, Baltimore, MD, USA.
L CollocaUniversity of Maryland School of Nursing, Department of Pain and Translational Symptom Science, Baltimore, USA; University of Maryland School of Medicine, Department of Anesthesiology, Baltimore, USA; UM Center to Advance Chronic Pain Research, Baltimore, MD, USA. Electronic address: colloca@son.umaryland.edu.
University of Maryland, Baltimore · USUniversität Hamburg · DEUniversity of Sydney · AU

Funding

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain PlasticityR01NR012686 · NINR · UNIVERSITY OF MARYLAND BALTIMORE · PI DORSEY, SUSAN G, SWEATT, JOHN DAVID · 2010 to 2014
$3.2M
Translational Phenotyping CoreP30NR014129 · NINR · UNIVERSITY OF MARYLAND BALTIMORE · PI DORSEY, SUSAN G · 2012 to 2016
$2.3M
Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systemsR01DE025946 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI COLLOCA, LUANA · 2016 to 2019
$2.1M
NIDCR NIH HHS R01 DE025946NINR NIH HHS P30NR014129NINR NIH HHS R01NR012686
6 · The paper itself

Abstract

Despite its initial treatment as a nuisance variable, the placebo effect is now recognized as a powerful determinant of health across many different diseases and encounters. This is in light of some remarkable findings ranging from demonstrations that the placebo effect significantly modulates the response to active treatments in conditions such as pain, anxiety, Parkinson's disease, and some surgical procedures. Here, we review pioneering studies and recent advances in behavioral, neurobiological, and genetic influences on the placebo effect. Consistent with recent conceptualizations, the placebo effect is presented as the product of a general expectancy learning mechanism in which verbal, conditioned, and social cues are centrally integrated to change behaviors and outcomes. Examples of the integration of verbal and conditioned cues, such as instructed reversal of placebo effects are also incorporated into this model. We discuss neuroimaging studies that have identified key brain regions and modulatory mechanisms underlying placebo effects using well-established behavioral paradigms. Finally, we present a synthesis of recent genetics studies on the placebo effect, highlighting a promising link between genetic variants in the dopamine, opioid, serotonin, and endocannabinoid pathways and placebo responsiveness. Greater understanding of the behavioral, neurobiological, and genetic influences on the placebo effect is critical for evaluating medical interventions and may allow health professionals to tailor and personalize interventions in order to maximize treatment outcomes in clinical settings.

Indexed as

Placebo EffectAnimalsBrainHumansNeuroimagingNeurotransmitter AgentsSignal TransductionNeurotransmitter Agentsconditioningexpectancylearningmodelingpain

Identifiers

PMID26272535
PMCPMC5367890
OpenAlexW1141235294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.